Meletios Athanasios Dimopoulos, Xavier P. Leleu, Meral Beksac, Ludek Pour, Roman Hajek, Zhuogang Liu, Jiri Minarik, Philippe Moreau, Joanna Romejko-Jarosińska, Ivan Špička, Vladimir I. Vorobyev, Elena Zamagni, Hartmut Goldschmidt, Thomas G. Martin, Robert Orlowski, Zandra Karina Klippel, Umer Khan, Sandrine Macé, Helgi Van de Velde, Thierry Facon. "Isatuximab, bortezomib, lenalidomide, and dexamethasone (Isa-VRd) in newly diagnosed multiple myeloma (NDMM): Outcomes in patients with 1q21+ status in the phase 3 IMROZ study.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.7517